Minimal Residual Disease (MRD) Testing News and reporting on minimal residual disease testing. Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients The study, called CORRECT-MRD II, is expected to enroll approximately 750 patients at 35 study sites in the US and Canada. Natera Signatera Test to be Used in Study of MRD-Guided Treatment for Colon Cancer Patients Patients will be randomized to receive various chemotherapy regimens depending on how Signatera identifies their minimal residual disease status. Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection Premium Both the MRD test, BR Prophet, and a six-cancer screening assay, BR Predict, are slated for launch in China next year, initially for contracted hospital customers. Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay Premium The firm said it will release its colorectal cancer test as an LDT next year and has reorganized its leadership to support future growth in the cancer screening market. Guardant Health Q2 Revenues Grow 39 Percent The firm's oncology testing revenues outpaced other revenue sources, driven by a more than 50 percent increase in clinical test volume. Aug 4, 2021 Adaptive Biotechnologies Q2 Revenues Jump 83 Percent Jul 28, 2021 Strata Oncology Raises $90M in Series C Financing Jul 26, 2021 Foresight Diagnostics Commercializing PhasED-seq Liquid Biopsy Tech for Improved MRD Detection Premium Jul 22, 2021 Natera Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes in New Study Premium Jul 20, 2021 C2i Genomics Teams With Premier for AI-Driven Minimal Residual Disease Detection Jul 13, 2021 Natera Inks Distribution Deal With TomaLab for Italy Jun 10, 2021 C2i Genomics, NovogeneAIT Genomics Partner to Launch Cancer Detection Platform in Southeast Asia Jun 9, 2021 Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications Jun 2, 2021 Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech May 28, 2021 Guardant Health Sues Natera for False Advertising, 'Misleading' Oncologists About MRD Tests May 25, 2021 F-Star Therapeutics to Use Inivata's RaDaR Assay in Clinical Studies May 19, 2021 Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows May 11, 2021 Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance May 7, 2021 Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium May 6, 2021 Guardant Health Q1 Revenues up 17 Percent Apr 28, 2021 NuProbe, AcornMed to Develop Cancer Minimal Residual Disease Detection Products Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Mar 27, 2021 Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients Premium Mar 15, 2021 Dana Farber Team Applies PCR Method to ID Microsatellite Instability in Tumor-Derived Samples Premium Mar 11, 2021 Broad Team to Improve Minimal Residual Disease Detection With Mutation Enrichment Sequencing Method Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.